New COVID booster guidelines limit eligibility for annual vaccinations

New FDA guidelines for COVID boosters in the U.S. align with European standards, limiting annual vaccinations to individuals over 65 and those aged 6 months to 64 with high-risk conditions like cancer, heart disease, and even broader issues such as obesity and depression. Critics express concerns about restricted vaccine access for those wanting to protect high-risk contacts, and vaccinations remain unavailable for healthy individuals in the 6 months to 64 years age group pending further studies.